Arterial Stent Market was valued at USD 7.5 Billion in 2022 and is projected to reach USD 10.6 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030.
The arterial stent market is a key segment in the global medical device industry, driven by the increasing prevalence of cardiovascular diseases (CVDs) and advancements in stent technologies. Arterial stents are small, expandable tubes inserted into narrowed or blocked arteries to restore blood flow. They are used in a variety of applications, such as treating atherosclerosis and other conditions that affect blood circulation. The market is categorized into different applications, each catering to a specific type of artery or vascular condition. This segmentation reflects the growing need for specialized treatments in the cardiovascular field. Some of the key applications include iliac arteries, carotid arteries, coronary arteries, femoral and popliteal arteries, and other vascular regions. Each of these categories plays a crucial role in ensuring the proper functioning of the arterial stent market, with ongoing innovations shaping the demand for better treatment outcomes and patient experiences.
Download Full PDF Sample Copy of Global Arterial Stent Report @ https://www.verifiedmarketreports.com/download-sample/?rid=481615&utm_source=Google_site&utm_medium=229
Iliac Artery
The iliac artery stent market segment is focused on treating conditions affecting the iliac arteries, which are responsible for supplying blood to the lower limbs and pelvis. Stenting procedures in the iliac arteries are typically used to address atherosclerotic blockages, which can result in peripheral artery disease (PAD). This application has witnessed significant growth due to an aging global population and increasing cases of PAD, a condition where plaque builds up in the arteries, restricting blood flow. The iliac artery stent market benefits from advanced stent designs, including drug-eluting stents (DES) and balloon-expandable stents, that provide better outcomes and reduced restenosis rates. With an increasing emphasis on minimally invasive procedures, the iliac artery stent market is expected to continue growing in response to both the aging population and a higher prevalence of cardiovascular risk factors, such as diabetes and hypertension.
In recent years, stenting procedures have evolved to offer enhanced durability and flexibility, contributing to improved patient outcomes in iliac artery stenting. The rising awareness about PAD and its complications is further fueling market growth, with physicians and healthcare providers increasingly adopting these stents for treating iliac artery blockages. Additionally, innovations in stent materials and coatings, such as bioresorbable stents, are likely to shape the future of this segment. The iliac artery stent market is set to expand as patients seek less invasive treatment options and as the number of individuals suffering from arterial blockages rises due to lifestyle factors and aging.
Carotid Artery
The carotid artery stent market focuses on the use of stents to treat blockages or narrowing of the carotid arteries, which supply blood to the brain. Carotid artery disease can lead to serious complications such as stroke, making this application highly critical in the prevention and management of cerebrovascular events. Carotid artery stenting (CAS) is an alternative to carotid endarterectomy (CEA) for patients who are deemed high-risk candidates for surgery. Stent procedures in this application are highly regulated and are generally performed with great caution to avoid complications like embolism or dissection. The growth of the carotid artery stent market is primarily driven by an increasing number of stroke-related cases, as well as the preference for minimally invasive approaches to treating carotid artery disease.
With advancements in technology, carotid artery stents have become more sophisticated, featuring designs that minimize the risk of restenosis and improve long-term outcomes. Drug-eluting stents, for example, are gaining popularity in this application, as they are coated with medication that helps prevent the formation of scar tissue. Moreover, the growing aging population and the rising incidence of risk factors like hypertension, smoking, and diabetes are expected to continue boosting demand for carotid artery stents. The future of this segment looks promising, with ongoing research and development focused on improving stent technology to offer safer and more effective treatments for carotid artery disease.
Coronary Artery
The coronary artery stent market is the largest and most established segment in the arterial stent industry, with coronary artery disease (CAD) being one of the leading causes of death worldwide. Coronary stents are used to open up blocked or narrowed coronary arteries that supply blood to the heart muscle. These stents are critical in the management of conditions like angina, myocardial infarction, and atherosclerosis. Coronary artery stents are typically made from materials like stainless steel or cobalt-chromium and are commonly used in conjunction with balloon angioplasty procedures. Over the years, coronary stenting has evolved from bare-metal stents (BMS) to more advanced drug-eluting stents (DES), which significantly reduce the risk of restenosis. The market has experienced rapid growth due to the increasing incidence of CAD, technological advancements, and growing patient preference for non-surgical interventions.
The coronary artery stent market is expected to continue to thrive as more patients opt for minimally invasive coronary interventions. Factors such as aging demographics, unhealthy lifestyles, and an increasing global prevalence of risk factors like hypertension and obesity are contributing to the continued demand for coronary stents. In addition, ongoing innovation in the stent design, including bioresorbable stents that dissolve over time, is likely to further boost market growth. The coronary artery stent segment is poised for further expansion, with a focus on improving patient outcomes through advanced materials, improved stent designs, and integrated technologies.
Femoral & Popliteal Artery
The femoral and popliteal artery stent market involves the use of stents to treat blockages in the arteries that supply blood to the lower limbs, specifically the femoral and popliteal arteries. Peripheral artery disease (PAD) often affects these arteries, leading to symptoms such as claudication, pain, and difficulty walking. The growth of the femoral and popliteal artery stent market is closely tied to the increasing prevalence of PAD, which is exacerbated by lifestyle factors like smoking, obesity, and diabetes. Interventions in these arteries have gained importance as part of a broader strategy to manage PAD and improve blood flow to the legs and feet. Stents designed for femoral and popliteal artery applications often come with advanced features to address the unique anatomical challenges of these arteries.
Technological advancements in the femoral and popliteal artery stent segment are focusing on increasing the durability and flexibility of stents, ensuring they can maintain patency for longer periods. Drug-eluting stents (DES) are increasingly used to reduce the occurrence of restenosis, which is a common challenge in this application. The rising global awareness of PAD and its impact on quality of life is expected to drive demand for these stents, along with the increasing adoption of minimally invasive techniques in the treatment of lower extremity arterial blockages. The femoral and popliteal artery stent market is projected to grow steadily as medical professionals seek effective solutions for managing PAD and restoring blood flow to the affected areas.
Other
The "Other" segment of the arterial stent market encompasses a wide range of stent applications for various arteries beyond the iliac, carotid, coronary, and femoral/popliteal categories. This segment includes arteries such as the renal, mesenteric, and subclavian arteries, each of which plays a crucial role in supplying blood to vital organs. Although these applications are less common, they are equally important for patients who experience blockages in these arteries. Stents used in these regions are typically designed with specific features to accommodate the unique anatomical and physiological requirements of each artery. The growth of this segment is driven by the increasing recognition of the need to treat blockages in these less conventional arteries and the growing availability of specialized stents for these applications.
As with other stent segments, advancements in technology are enhancing the effectiveness of stents in these arteries, with drug-eluting stents and bioresorbable materials being incorporated into treatments. The "Other" stent market segment is expected to grow due to a combination of rising demand for less invasive treatment options, as well as the increasing prevalence of conditions like renal artery stenosis and mesenteric ischemia. The continued development of stent technologies tailored to these unique arterial applications will likely fuel further growth in the market segment, expanding its reach beyond traditional uses.
The arterial stent market is witnessing several key trends, including the growing shift toward minimally invasive procedures, the increasing demand for drug-eluting stents, and the ongoing development of bioresorbable stents. Minimally invasive techniques are gaining popularity due to their ability to reduce patient recovery time and minimize surgical risks. The increasing prevalence of cardiovascular diseases is also contributing to the rise in stent procedures, further fueling market growth. Additionally, technological advancements in stent design and materials are providing new opportunities for market players to develop more effective and safer stents, improving patient outcomes.
Opportunities in the arterial stent market are also being driven by the expansion of healthcare infrastructure in emerging markets, where the demand for cardiovascular treatments is rising. With greater access to medical services and increasing awareness of vascular health, these markets present untapped potential for the growth of the arterial stent industry. Furthermore, the aging population in developed nations is driving demand for stents to treat age-related cardiovascular conditions. Ongoing research and innovation are likely to lead to the development of stents that offer improved efficacy, reduced complications, and greater patient satisfaction, providing significant growth prospects in the market.
1. What is the purpose of an arterial stent?
An arterial stent is a small tube inserted into an artery to
Download Full PDF Sample Copy of Global Arterial Stent Report @ https://www.verifiedmarketreports.com/download-sample/?rid=481615&utm_source=Google_site&utm_medium=229
Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
C.R. Bard Inc.
Cook Medical
Medtronic
Gore Medical
Lifetech Scientific
Biosensors International Group Ltd.
Biotronik AG
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @Â https://www.verifiedmarketreports.com/ask-for-discount/?rid=481615&utm_source=Google_site&utm_medium=229
Growing demand for below applications around the world has had a direct impact on the growth of the Global Arterial Stent Market
Iliac Artery
Carotid Artery
Coronary Artery
Femoral & Popliteal Artery
Other
Based on Types the Market is categorized into Below types that held the largest Arterial Stent market share In 2023.
Coronary Stents
Peripheral Stents
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
1. Introduction of the Global Arterial Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Arterial Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Arterial Stent Market, By Type
6. Global Arterial Stent Market, By Application
7. Global Arterial Stent Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Arterial Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/